1H-CINNOLIN-4-ONE
1H-CINNOLIN-4-ONE Basic information
- Product Name:
- 1H-CINNOLIN-4-ONE
- Synonyms:
-
- 1H-CINNOLIN-4-ONE
- [1,8]NAPHTHYRIDIN-4-OL
- 4(1H)-Cinnolinone
- 1,4-dihydrocinnolin-4-one
- CAS:
- 18514-84-6
- MF:
- C8H6N2O
- MW:
- 146.15
- Mol File:
- 18514-84-6.mol
1H-CINNOLIN-4-ONE Chemical Properties
- storage temp.
- Sealed in dry,Room Temperature
- Appearance
- Brown to reddish brown Solid
1H-CINNOLIN-4-ONE Usage And Synthesis
Synthesis Reference(s)
Synthesis, p. 288, 1987 DOI: 10.1055/s-1987-27921
Synthesis
551-93-9
18514-84-6
General procedure for the synthesis of 1H-cinnolin-4-one from o-aminoacetophenone: Preparation of Intermediate 1: 1,4-dihydro-4-quinolinone: An aqueous solution (10 mL) of sodium nitrite (4.0 g, 59 mmol) was slowly added dropwise over 20 min to a stirred mixture of 2-aminoacetophenone (5.0 g, 37.03 mmol) with concentrated hydrochloric acid (31 mL) under ice bath cooling conditions. The reaction mixture was continued to be stirred at the same temperature for 2 hours, then brought to room temperature and stirred overnight. After completion of the reaction, the mixture was concentrated under reduced pressure. The residue was neutralized with aqueous sodium acetate and then subjected to post-extraction treatment (ethyl acetate/brine) to give the final 1H-cinnolin-4-one (1.25 g, 23% yield). 1H-NMR (δ ppm, DMSO-d6, 300 MHz): 13.48 (br.s, 1H); 8.01 (d, J = 8.1 Hz, 1H); 7.82-7.73 (m, 2H); 7.57 (d, J = 8.1 Hz, 1H); 7.41 (t, J = 7.8 Hz, 1H).
References
[1] Heterocycles, 2008, vol. 75, # 1, p. 77 - 86
[2] Australian Journal of Chemistry, 1981, vol. 34, # 12, p. 2619 - 2627
[3] Patent: WO2009/53799, 2009, A1. Location in patent: Page/Page column 28-29
[4] Journal of the Chemical Society, 1947, p. 917,920
1H-CINNOLIN-4-ONESupplier
- Tel
- 13817811078
- sales@jingyan-chemical.com
- Tel
- 0531-88811783
- sales@trio-pharmatech.com
- Tel
- 86(512)5235 8471 17715136450
- sales@shiyabiopharm.com
- Tel
- 0592-6266840 15750707980
- sales@chemsdano.com
- Tel
- 400-400-164-7117 18317119277
- product02@bidepharm.com